Stampa…

GW 9508 ≥98% (by TLC)

Fornitore: ENZO LIFE SCIENCES AG
Pericolo

Synonyms: GPR40 Agonist, GW9508, 4-[[(3-Phenoxyphenyl)methyl]amino]benzene propanoic acid, GW-9508, 3-(4-((3-Phenoxybenzyl)amino)phenyl)propanoic acid, 3-(4-(((3-(Phenoxy)phenyl)methyl)amino)phenyl)propanoic acid, Free Fatty Acid Receptor 1 Agonist I, FFA1 Agonist I

BMLGP1020010 BMLGP1020050
ENZOBMLGP1020010EA 86.9 EUR
ENZOBMLGP1020010 ENZOBMLGP1020050
GW 9508 ≥98% (by TLC)
GW 9508

High potency synthetic agonist at GPR40.


First high potency synthetic agonist at GPR40. Enhanced insulin secretion in INS-1E cells and activates ATP-sensitive potassium channels in rat pancreatic beta cells (40 μM). It is used as a tool for exploring the biology of GPR40 mediated signaling and physiology.


Soluble in DMSO (15 mg/ml).

Formula: C₂₂H₂₁NO₃
Peso molecolare: 347,414 g/mol
Temperatura di stoccaggio: Ambiente
MDL Number: MFCD09753282
CAS Number: 885101-89-3
UN: 3077
ADR: 9,III
https://digitalassets.avantorsciences.com/adaptivemedia/rendition?id=aefa78822ccca4bca354571b1d2de22b9b7f2d16&vid=fbdf4b7b55900761131096e2eca0f54637df77a5&prid=web&clid=SAPDAM

Visualizza i codici

Risultati del test di specificazione

Purity ≥98% (TLC)

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Informazioni About VWR